268 related articles for article (PubMed ID: 37652576)
1. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
[TBL] [Abstract][Full Text] [Related]
2. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
3. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
4. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
5. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
6. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
Front Immunol; 2020; 11():89. PubMed ID: 32184777
[TBL] [Abstract][Full Text] [Related]
7. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract][Full Text] [Related]
8. M1
Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
[TBL] [Abstract][Full Text] [Related]
9. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro.
Wang X; Wei S; Li W; Wei X; Zhang C; Dai S; Ma M; Zhao L; Shan B
Int Immunopharmacol; 2023 Jun; 119():110213. PubMed ID: 37137266
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
11. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
Chen D; Xie J; Fiskesund R; Dong W; Liang X; Lv J; Jin X; Liu J; Mo S; Zhang T; Cheng F; Zhou Y; Zhang H; Tang K; Ma J; Liu Y; Huang B
Nat Commun; 2018 Feb; 9(1):873. PubMed ID: 29491374
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
[TBL] [Abstract][Full Text] [Related]
14. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
16. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778
[TBL] [Abstract][Full Text] [Related]
17.
Zhang W; Xu L; Zhang X; Xu J; Jin JO
Front Immunol; 2023; 14():1213467. PubMed ID: 37720226
[TBL] [Abstract][Full Text] [Related]
18. YAP/STAT3 inhibited CD8
Wang C; Shen N; Guo Q; Tan X; He S
Cancer Med; 2023 Aug; 12(15):16295-16309. PubMed ID: 37329188
[TBL] [Abstract][Full Text] [Related]
19. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
[TBL] [Abstract][Full Text] [Related]
20. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.
Luo F; Li H; Ma W; Cao J; Chen Q; Lu F; Qiu M; Zhou P; Xia Z; Zeng K; Zhan J; Zhou T; Luo Q; Pan W; Zhang L; Lin C; Huang Y; Zhang L; Yang D; Zhao H
Cell Mol Immunol; 2024 Jan; 21(1):60-79. PubMed ID: 38062129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
